Karuna Therapeutics, Inc. Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc.

KRTX

Pozycja w akcjach #2109
Operating as a clinical-stage biopharmaceutical firm, Karuna Therapeutics, Inc.... Operating as a clinical-stage biopharmaceutical firm, Karuna Therapeutics, Inc. is dedicated to pioneering innovative therapies for individuals afflicted by psychiatric and neurological disorders. Its primary investigational compound, KarXT, is an oral agent designed to modulate muscarinic receptors. Currently in Phase III clinical trials, KarXT is being evaluated for several indications: the treatment of acute psychosis in schizophrenia patients, the amelioration of central nervous system conditions (including the negative and cognitive symptoms associated with schizophrenia and general psychosis), and the management of dementia-related psychosis. Beyond KarXT, the firm is also advancing a pipeline of other drug candidates that interact with muscarinic receptors. Karuna Therapeutics, Inc. has forged several strategic partnerships, encompassing licensing agreements with Eli Lilly and Company and Zai Lab (Shanghai) Co., Ltd., a patent license with PureTech Health LLC, and drug discovery collaborations with Charles River Laboratories and PsychoGenics, Inc. Established in 2009, the enterprise initially operated under the name Karuna Pharmaceuticals, Inc., before officially adopting its current corporate identity, Karuna Therapeutics, Inc., in March 2019. Its corporate headquarters are located in Boston, Massachusetts.
Cena akcji
$329.83
Ostatnia synchronizacja: 2024-03-18
Kapitalizacja rynkowa
$9.75B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Karuna Therapeutics, Inc. (KRTX)

Kategoria

Healthcare
Historia podziałów akcji dla Karuna Therapeutics, Inc. (KRTX)
Akcje Karuna Therapeutics, Inc. (symbol: KRTX) przeszły łącznie 0 podziałów.
Najnowszy podział miał miejsce Oct 21, 2026.
Jedna akcja KRTX kupiona przed Oct 21, 2026 odpowiada dziś 0 akcjom KRTX.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
Za mało danych dla podanych dat.
Podziały akcji dla podobnych firm lub konkurencji
Firma Liczba podziałów akcji Skumulowany mnożnik Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH